NCT01038011View on ClinicalTrials.gov

Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2004

Study Completion Date

August 31, 2006

Conditions
Ankylosing Spondylitis
Interventions
DRUG

drug treatment

Trial Locations (1)

Unknown

Zurich

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Zurich

OTHER